Anthony Chan Tak Cheung

Scientific Advisor at Tessa Therapeutics

Professor Anthony Chan is Li Shu Fan Professor of Clinical Oncology; Director of the Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute; Chief Director of Phase I Clinical Trial Centre and Associate Dean (External Affairs) at the Chinese University of Hong Kong.

Professor Chan has conducted pivotal studies setting new treatment standards in multimodality approaches in nasopharynx cancer, developed the clinical application of the biomarker EBV DNA and pioneered immunotherapeutic and targeted therapeutics in this disease. He has published over 260 peer-reviewed papers, 49 book chapters and reviews, and delivered over 150 international lectures. He has also served on the Editorial Board of Journal of Clinical Oncology and is currently Associate Editor of Annals of Oncology.

Professor Chan obtained his MBBS in University College Hospital and Middlesex Joint School of Medicine in London and completed his postgraduate training in the U.K. at the Royal Marsden Hospital.